Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Gershon

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Science Advances|January 26, 2022
Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertibChaemin Lim, Taylor Dismuke, Daniel Malawsky, et al.
Cell Death & Disease|December 7, 2021
Oligodendrocytes depend on MCL-1 to prevent spontaneous apoptosis and white matter degenerationAbigail H Cleveland, Alejandra Romero-Morales, Laurent Alfonso Azcona, et al.
Communications Biology|May 22, 2021
Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profileDaniel Shiloh Malawsky, Seth J Weir, Jennifer Karin Ocasio, et al.
Cancer Research|May 20, 2016
Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic PathwayAndrew J Crowther, Jennifer K Ocasio, Fang Fang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 1, 2020
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicityDuhyeong Hwang, Taylor Dismuke, Andrey Tikunov, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Nanoparticle-delivered resiquimod induces brain tumor regression in medulloblastoma and diffuse midline glioma models by interrupting paracrine growth support and activating myeloid immune signaling and phagocytosisLeon McSwain, Kyongtea Kim, Duhyeong Hwang, et al.
The Journal of Experimental Medicine|October 13, 2010
Tbata modulates thymic stromal cell proliferation and thymus functionFrancis A Flomerfelt, Nahed El Kassar, Chandra Gurunathan, et al.
Development (Cambridge, England)|October 10, 2015
Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in miceScott E Williams, Idoia Garcia, Andrew J Crowther, et al.
Molecular Cancer|October 19, 2010
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastomaIdoia Garcia, Gemma Mayol, Eva Rodríguez, et al.
Science Advances|July 20, 2022
Noncanonical activation of GLI signaling in SOX2<sup>+</sup> cells drives medulloblastoma relapseMarzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Science Advances|January 26, 2022
Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertibChaemin Lim, Taylor Dismuke, Daniel Malawsky, et al.
Cell Death & Disease|December 7, 2021
Oligodendrocytes depend on MCL-1 to prevent spontaneous apoptosis and white matter degenerationAbigail H Cleveland, Alejandra Romero-Morales, Laurent Alfonso Azcona, et al.
Communications Biology|May 22, 2021
Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profileDaniel Shiloh Malawsky, Seth J Weir, Jennifer Karin Ocasio, et al.
Cancer Research|May 20, 2016
Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic PathwayAndrew J Crowther, Jennifer K Ocasio, Fang Fang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 1, 2020
Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicityDuhyeong Hwang, Taylor Dismuke, Andrey Tikunov, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Nanoparticle-delivered resiquimod induces brain tumor regression in medulloblastoma and diffuse midline glioma models by interrupting paracrine growth support and activating myeloid immune signaling and phagocytosisLeon McSwain, Kyongtea Kim, Duhyeong Hwang, et al.
The Journal of Experimental Medicine|October 13, 2010
Tbata modulates thymic stromal cell proliferation and thymus functionFrancis A Flomerfelt, Nahed El Kassar, Chandra Gurunathan, et al.
Development (Cambridge, England)|October 10, 2015
Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in miceScott E Williams, Idoia Garcia, Andrew J Crowther, et al.
Molecular Cancer|October 19, 2010
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastomaIdoia Garcia, Gemma Mayol, Eva Rodríguez, et al.
Science Advances|July 20, 2022
Noncanonical activation of GLI signaling in SOX2<sup>+</sup> cells drives medulloblastoma relapseMarzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, et al.
Pageof 4